Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis

被引：3
|
作者：
Gupta, Rachit [1 ]
Schulberg, Julien D. [1 ]
Niewiadomski, Ola [1 ]
Wright, Emily K. [1 ]
机构：
[1] St Vincents Hosp Melbourne Pty Ltd, Gastroenterol, 41 Victoria Parade, Fitzroy, 3065, Australia
来源：
AUTOIMMUNITY REVIEWS | 2022年 / 21卷 / 07期
关键词：
D O I：
10.1016/j.autrev.2022.103115
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical, and endoscopic remission in refractory moderate to severe ulcerative colitis
    Gupta, R.
    Schulberg, J.
    Niewiadomski, O.
    Wright, E. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 115 - 115
  • [2] Remission induction therapy with tacrolimus and biological combination therapy for severe ulcerative colitis
    Ito, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S331 - S331
  • [3] USTEKINUMAB IS EFFECTIVE FOR INDUCING CLINICAL, ENDOSCOPIC, AND RADIOGRAPHIC RESPONSE AND REMISSION IN REFRACTORY MODERATE-TO-SEVERE CROHN'S DISEASE: A MULTICENTRE COHORT STUDY
    Ma, Christopher
    Fedorak, Richard N.
    Kaplan, Gilaad
    Dieleman, Levinus A.
    Devlin, Shane M.
    Stern, Nathan
    Kroeker, Karen I.
    Seow, Cynthia H.
    Leung, Yvette
    Novak, Kerri L.
    Halloran, Brendan P.
    Huang, Vivian
    Wong, Karen
    Ghosh, Subrata
    Panaccione, Remo
    GASTROENTEROLOGY, 2017, 152 (05) : S410 - S411
  • [4] An endoscopic therapeutic goal to maintain remission with tacrolimus in refractory ulcerative colitis
    Ito, A.
    Kuriyama, T.
    Omori, T.
    Yonezawa, M.
    Iizuka, N.
    Shiratori, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S126 - S126
  • [5] Upadacitinib appears effective in inducing clinical, biochemical, endoscopic and histologic improvements in previously treatment refractory Ulcerative Colitis
    Choon, X. Y.
    Patel, C.
    White, C.
    Centritto, A.
    Lal, N.
    Sharma, E.
    Chester, D.
    Dart, R.
    Anderson, S.
    Ray, S.
    Mawdsley, J.
    Irving, P.
    Samaan, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1917 - I1917
  • [6] COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Hu, Anne
    Kotze, Paulo G.
    Tan, William
    Jess, Alison T.
    Li, Pei-Shun Mimi
    Kroeker, Karen I.
    Halloran, Brendan P.
    Panaccione, Remo
    Ma, Christopher
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2020, 158 (06) : S53 - S53
  • [7] Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis
    Ganzleben, Ingo
    Hirschmann, Simon
    Naegel, Andreas
    Glueck, Christian
    Rath, Timo
    Neurath, Markus F.
    Gimped, Carol
    Osaba, Lourdes
    Nagore, Daniel
    Hoffman, Arthur
    Atree, Raje
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [8] Combined therapy of tacrolimus and vedolizumab in severe refractory ulcerative colitis
    Dietrich, N. -A.
    Baer, F.
    Dignass, A.
    Bokemeyer, B.
    Fellermann, K.
    Buening, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S394 - S394
  • [9] MODERATE TO SEVERE ENDOSCOPIC INFLAMMATION IS FREQUENT AFTER ACHIEVING CLINICAL REMISSION IN PEDIATRIC ULCERATIVE COLITIS
    Sarbagili-Shabat, Chen
    Weiner, Dror
    Wardi, Joram
    Abramas, Lee
    Yaakov, Michal
    Levine, Arie
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S13 - S13
  • [10] Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis
    Sarbagili-Shabat, Chen
    Weiner, Dror
    Wardi, Joram
    Abramas, Lee
    Yaakov, Michal
    Levine, Arie
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (04): : 569 - 573
12345